Our platform focuses on simplifying stock market information through structured analysis of earnings, trends, and financial news.
As of 2026-04-08, Keros Therapeutics Inc. (KROS) is trading at a current price of $12.5, marking a 2.12% gain on the day. This analysis examines key technical levels, recent market context, and potential future scenarios for the biotech stock, with no recent earnings data available for the company as of this publication. KROS has seen relatively range-bound trading in recent weeks, with price action largely tied to broader biotech sector flows rather than company-specific news. Key takeaways for
Is Keros Therapeutics (KROS) Stock heavily shorted | Price at $12.50, Up 2.12% - Max Pain Level
KROS - Stock Analysis
3100 Comments
698 Likes
1
Jayline
New Visitor
2 hours ago
{协议答案}
👍 284
Reply
2
Jahri
Engaged Reader
5 hours ago
{协议答案}
👍 66
Reply
3
Tamatha
Expert Member
1 day ago
{协议答案}
👍 151
Reply
4
Hans
Insight Reader
1 day ago
{协议答案}
👍 70
Reply
5
Isiaha
Influential Reader
2 days ago
{协议答案}
👍 231
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.